Back to Journals » International Journal of General Medicine » Call For Papers

International Journal of General Medicine

COPE logo
ISSN: 1178-7074

The following Article Collection/ Thematic Series is currently open for submissions:

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Today in Pulmonary Medicine from the Bench to Bedside and Beyond" in the International Journal of General Medicine.

The International Journal of General Medicine seeks to publish innovations in clinical, translational, and basic science that improve our knowledge and management of pulmonary diseases. Although the scope of pulmonary medicine is vast, we seek impactful contributions that use state-of-the-art approaches to promote lung health in the areas of obstructive airways disease, fibrosis, pulmonary hypertension, sleep, neural control of breathing, environmental medicine, and population health. Topics may also include new therapeutics, biomarkers, diagnostics, devices, and new research methodology.

Lung diseases represent one of the most widespread and severe categories of medical conditions globally. In the United States alone, tens of millions of people are affected by various forms of lung disease, ranging from mild respiratory issues to life-threatening conditions. These diseases include chronic obstructive pulmonary disease (COPD), asthma, pulmonary fibrosis, and lung cancer, among others. The primary causes of lung disease are well established: tobacco smoke—both firsthand and secondhand exposure—remains the leading risk factor. In addition, respiratory infections such as pneumonia and influenza can significantly damage lung function, particularly in vulnerable populations. Genetic factors also play a critical role, with inherited conditions like cystic fibrosis contributing to chronic respiratory problems. Environmental pollutants, occupational exposures, and lifestyle factors further compound the risk, making lung health a critical area of public health concern.

Article types such as Original Research, Reviews and Commentaries are welcomed. Case reports/series are not sought; any submitted to the International Journal of General Medicine will be diverted to the International Medical Case Reports Journal.

Topics of interest include but are not limited to:
Innovative pulmonary therapeutics

  • Chronic obstructive pulmonary disease (COPD)
  • Pulmonary hypertension
  • Pulmonary fibrosis
  • Genetic factors of pulmonary health
  • Environmental and lifestyle factors affecting pulmonary health

Keywords

1 Respiratory
2. Lung
3. Airways
4. Fibrosis
5. Population health

All manuscripts submitted to the Article Collection will undergo a full peer-review; the Guest Advisor for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code 5E564  to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is 31 July 2026.

Guest Advisor

Professor Reynold A. Panettieri, Jr., MD, Rutgers University, New Brunswick, NJ USA

[email protected]

 

View all papers in this article collection

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Innovations and Integrations in regenerative medicine" in the International Journal of General Medicine.

Regenerative medicine is increasingly recognized as a central pillar of future healthcare. Unlike conventional treatments that primarily focus on managing symptoms, regenerative approaches aim to restore or replace damaged tissues and organs. This shift is particularly important as chronic diseases, degenerative conditions, and organ failure continue to increase in prevalence worldwide. Advances in stem cell biology, biomaterials, tissue engineering, gene editing, and immunomodulation are driving progress toward therapies that have the potential to provide lasting functional recovery. This Collection, "Innovations and Integrations in Regenerative Medicine" presents recent developments that demonstrate scientific discoveries and how they are being translated into clinical practice. By bringing together contributions from basic science, translational research, and clinical studies, the series highlights the potential of regenerative strategies to redefine treatment pathways and set new standards of care in modern medicine.

Regenerative medicine tackles health problems that current treatments often fail to resolve. Chronic conditions such as heart disease, diabetes, neurodegenerative disorders, and organ failure are typically managed, not cured. Regenerative approaches seek to restore the structure and function of damaged tissues and organs, directly addressing root causes rather than symptoms. This field promises to overcome critical limitations like organ transplant shortages and immune rejection by enabling growth or restoration of tissues using a patient’s own cells. It also holds cross-cutting potential for different targets, such as cardiovascular repair, neurological disorders, autoimmune diseases, and more. There are many of these therapies have already reached clinical or commercial stages, including FDA-approved treatments for wounds and orthopedic injuries, strengthening the path from research to real-world impact.

This Collection centers on regenerative medicine within the framework of internal medicine, reflecting the journal's commitment to enhancing understanding of pathogenesis, diagnosis, treatment protocols, patient outcomes, and quality of life. It invites contributions that explore areas such as stem-cell therapies, biomaterial innovations, tissue engineering, gene editing, immune modulation, and their clinical applications in cardiovascular, endocrine, neurological, and multi-system diseases. Articles that integrate basic research and clinical trials are especially welcome.

Keywords

  1. Regenerative Medicine
  2. Stem Cell Therapy
  3. Tissue engineering
  4. Biomaterials
  5. Translational Medicine

All manuscripts submitted to the Article Collection will undergo a full peer-review; the Guest Advisors for this collection will not be handling the manuscripts (unless they are an Editorial Board member). Please review the journal scope and author submission instructions prior to submitting a manuscript.

Please submit your manuscript on our website, quoting the promo code 9D1C8 to indicate that your submission is for consideration in this Article Collection. The deadline for submitting manuscripts is July 6 2026.

Guest Advisors

Ke Huang, Texas A&M University

[email protected]

Dashuai Zhu, Columbia University 

[email protected]

Dr. Dashuai Zhu is a biomedical researcher specializing in regenerative medicine and therapeutic biomaterials. His work focuses on engineering advanced delivery platforms to promote tissue repair and modulate immune responses. Dr. Zhu has contributed extensively to translational research, bridging innovative laboratory discoveries with clinical applications.

Panagiotis Tasoudis, UNC Hospital 

[email protected]

Dr. Panagiotis Tasoudis is a surgery resident with a strong focus on advanced cardiothoracic procedures and transplant medicine. His clinical and research interests include lung and heart transplantation, LVAD therapy, aortic disease management, and regenerative medicine. Dr. Tasoudis is dedicated to integrating surgical innovation with translational research to improve patient outcomes.

 

View all papers in this article collection

Call For Papers


To see where the International Journal of General Medicine is indexed online view the Journal Metrics.

What is the advantage to you of publishing in the International Journal of General Medicine?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Although the International Journal of General Medicine receives a large number of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. The International Journal of General Medicine has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed
The International Journal of General Medicine is indexed on PubMed Central (title abbreviation: Int J Gen Med). All published papers in this journal are submitted to PubMed for indexing straight away.

Become a Favored Author and receive real benefits
If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely
Professor Kenneth Adler
Editor-in-Chief
International Journal of General Medicine

Email: Editor-in-Chief

Updated 11 July 2024